bovnews1d
What’s Behind the 0.48% Gain in United Therapeutics Corporation (UTHR) Stock? Find Out Now!
United Therapeutics Corporation (UTHR) stock saw a modest uptick, ending the day at $353 which represents a slight increase of $1.67 or 0.48% from the prior close of $351.33. The stock opened at $349.
United Therapeutics (UTHR) Is Thriving on Strong Demand and Smart Pricing
We recently published a list of 16 Best Mid Cap Growth Stocks To Buy Now. In this article, we are going to take a look at ...
Butler Eagle2d
Meet the Pittsburgh Riveters. Expansion USL W club gets name, logo ahead of 2025 debut
Five months after Pittsburgh was announced as an expansion franchise in the United Soccer League W, the club has an official ...
Smaller Rivals Grab Market Share From United Health Tech Unit After Hack
The February cyberattack that snarled its Change Healthcare IT business created an opportunity for competitors, who say they ...
The United Federation of Teachers Welfare Fund Partners with Hospital for Special Surgery to Offer HSS Perform, Guided Access to Musculoskeletal Care
Welfare Fund and Hospital for Special Surgery (HSS), the world's leading academic medical center focused on musculoskeletal health, announced a partnership today to offer HSS Perform, a program for ...
4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day
D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on ...
Business Insider6d
Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million
Dr. Roger Jeffs, Ph.D., Chief Executive Officer of Liquidia, stated: “We are pleased with the court’s decision to find United Therapeutics liable for its interference with the launch of generic ...